• Brain tumors in patients with myotonic dystrophy: a population-based study.

      Gadalla, S M; Pfeiffer, R M; Kristinsson, S Y; Björkholm, M; Landgren, O; Greene, M H; [ 1 ] NCI, Clin Genet Branch, Div Canc Epidemiol & Genet, NIH, 9609 Med Ctr Dr, Bethesda, MD 20892 USA [ 2 ] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, 9609 Med Ctr Dr, Bethesda, MD 20892 USA [ 3 ] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden [ 4 ] Karolinska Inst, Stockholm, Sweden [ 5 ] Univ Iceland, Fac Med, Reykjavik, Iceland [ 6 ] Landspitali Natl Univ Hosp, Dept Hematol, Reykjavik, Iceland   Organization-Enhanced Name(s)      Landspitali National University Hospital [ 7 ] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA (Wiley-Blackwell, 2016-03)
      Patients with myotonic dystrophy (DM) are at high risk of brain cancer. This study describes the spectrum of brain neoplasms in DM patients.